An observational study in Antibiotic Prescription, sponsored by Imperial College London. Completed. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2022-02-03.
Sponsored by Imperial College London · Observational
This is an observational study assessing the management and outcome of children presenting to Emergency Departments (ED) with fever across Europe.
This is an observational study assessing the management and outcome of children presenting to Emergency Departments (ED) with fever across Europe. This study will use large departmental datasets to collect information on at least 50,000 febrile episodes . This study will use large-scale, pseudo-anonymized departmental data, and will not involve consented patient recruitment; nor will it use patient samples. Data included in MOFICHE will be based on that collected as part of routine clinical care. Antibiotic prescription, hospitalisation and number/type of investigations, re-attendance at ED within 5 days of the first hospital presentation will be recorded.
Imperial College London is the lead sponsor of 824 studies on the registry; 178 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Febrile children aged 0- 18 years visiting the emergency care.
Exclusion Criteria:
-
Antibiotic prescription
number of antibiotic prescriptions
Time frame: one year
hospitalization
number of children requiring admission to hospital
Time frame: one year
Number of investigations
number of investigations
Time frame: one year
Number of children re-attending within 5 days of the first hospital presentation.
Number of re-attendance
Time frame: one year
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Imperial College London